Skip to main content

Ganot Ilan's Form 4 filing

Solid Biosciences Inc. (SLDB) · filed Jun 8, 2023

Accession no.
0000899243-23-014999
Filed
Jun 8, 2023
Trade date
May 2-Jun 6, 2023
Filing delay
37 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.36K. It was filed 37 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ganot IlanCIK 0001727460Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 2, 2023Common StockMOption exerciseAcquired+1,553–F1–4,640Indirect
May 2, 2023Common StockSSaleDisposed−487$4.85−$2,361.954,153Indirect
Jun 2, 2023Common StockMOption exerciseAcquired+1,583–F1–87,758Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 2, 2023Common StockMOption exerciseDisposed−1,553$0.00$01,553Indirect
Jun 2, 2023Common StockMOption exerciseDisposed−1,583$0.00$03,166Direct
Jun 6, 2023Common StockAGrant or awardAcquired+9,650$0.00$09,650Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Restricted stock units convert into common stock on a one-for-one basis.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)